Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Fulgent Genetics, Inc. (FLGT) had Normalized Pre-Tax Income of $-29.69M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$85.39M |
|
$-29.53M |
|
$59.71M |
|
$25.68M |
|
$121.46M |
|
$-36.07M |
|
$6.38M |
|
$-29.69M |
|
|
Normalized Pre-Tax Income |
$-29.69M |
$-29.72M |
|
$-29.72M |
|
$-29.72M |
|
$-29.72M |
|
$-36.07M |
|
$-29.14M |
|
28.00M |
|
28.00M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$454.77M |
|
$113.07M |
|
$634.45M |
|
$1.09B |
|
$71.76M |
|
-- |
|
$21.48M |
|
$93.24M |
|
$995.99M |
|
$861.36M |
|
$995.99M |
|
27.52M |
|
| Cash Flow Statement Financials | |
$-16.66M |
|
$61.74M |
|
$-69.06M |
|
$50.33M |
|
$26.44M |
|
$-23.89M |
|
$18.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.34 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
30.07% |
|
-42.25% |
|
-42.25% |
|
-- |
|
-34.77% |
|
-34.58% |
|
$-25.71M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
1.31 |
|
68.44 |
|
-2.98% |
|
-3.45% |
|
-2.73% |
|
-2.98% |
|
$36.20 |
|
$-0.92 |
|
$-0.59 |
|